Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
Details for Australian Patent Application No. 2006326662 (hide)
International Classifications
Event Publications
10 July 2008 PCT application entered the National Phase
PCT publication WO2007/070359 Priority application(s): WO2007/070359
28 July 2011 Application Accepted
Published as AU-B-2006326662
1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
12 January 2012 Section 223 Application Allowed
Amgen Inc. The time in which to pay the acceptance fee has been extended to 28 Nov 2011. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000 2008
19 January 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006326665-Indolone compounds useful to treat cognitive impairment
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser